A carregar...
Cost–Utility Analysis of Nivolumab in Adjuvant Treatment of Melanoma in France
INTRODUCTION: The aim of the current study is to estimate the cost-effectiveness of adjuvant treatment with nivolumab relative to clinically relevant comparators in adult patients with melanoma with lymph node involvement or metastatic disease who have undergone complete resection from a French soci...
Na minha lista:
| Publicado no: | Dermatol Ther (Heidelb) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Healthcare
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7649185/ https://ncbi.nlm.nih.gov/pubmed/32920709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-020-00446-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|